Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
NCT05957380
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
DA-2803
DRUG:
DA-2803-R
DRUG:
Placebo of DA-2803
DRUG:
Placebo of DA-2803-R
Sponsor
Dong-A ST Co., Ltd.